Integra LifeSciences Holdings Corporation stock is up 3.87% since 30 days ago. The next earnings date is Feb 21, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58.62% of the previous 28 December’s closed higher than November. 100% of analysts rate it a buy.
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, surgical headlamps and instrumentation.